LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 1.20 $ 0.00 (0 %)    

Friday, 17-Oct-2025 05:56:46 EDT
QQQ $ 593.14 $ 0.00 (0 %)
DIA $ 456.22 $ 0.00 (0 %)
SPY $ 654.69 $ 0.00 (0 %)
TLT $ 91.57 $ 0.00 (0 %)
GLD $ 399.19 $ 0.00 (0 %)
$ 1.23
$ 1.25
$ 1.20 x 100
$ 1.25 x 6
-- - --
$ 1.12 - $ 33.66
480,208
na
28.66M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-04-2025 06-30-2025 10-Q
2 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with ...

 us-stocks-likely-to-open-higher-sp-500-sees-average-gain-of-61-in-2nd-half-expert-says

U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION